XML 61 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Increase in revenue adjustment   $ 9,000,000.0  
Decrease in net loss   $ 9,000,000.0  
Decrease in net loss per share   $ 0.02  
Revenue recognized $ 46,600,000 $ 31,900,000  
Total restricted cash 8,400,000 8,600,000  
Impairment charges 0 0 $ 0
Impairment of long-lived assets 10,126,000 0 0
Finance leases 0    
Advertising costs 49,100,000 54,700,000 11,200,000
Deferred Advertising Costs 1,600,000 700,000  
K I T S      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Revenue recognized 27,700,000 21,900,000 24,100,000
Research Services      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Revenue recognized 9,700,000 31,400,000  
Remaining performance obligations 21,600,000    
Deferred revenue for customer services 14,000,000.0 11,600,000 31,900,000
Contract with customer liability revenue recognized related party amount 9,200,000 30,100,000  
Consumer services      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Deferred revenue for customer services $ 48,600,000 $ 51,300,000 $ 39,300,000
Employee Stock Purchase Plan      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Payroll deductions to participate in plan 15.00%    
Employee Stock Purchase Plan | Class A Common Stock [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Discount from market price, offering date 85.00%    
Discount from market price, purchase date 85.00%    
Maximum value of shares per employee $ 25,000    
Supplier Concentration Risk | Revenue | Microarrays      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Percentage of Revenue 100.00% 100.00% 100.00%
Supplier Concentration Risk | Revenue | K I T S      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Percentage of Revenue 100.00% 100.00% 100.00%
Supplier Concentration Risk | Revenue | Laboratory Services      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Percentage of Revenue 100.00% 100.00% 100.00%